Sat.Jul 06, 2024

article thumbnail

Opinion: First Opinion readers respond to psychiatry and social contracts, Medicare and weight loss meds, and more

STAT

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.

309
309
article thumbnail

China Leads in AI-Driven Drug Discovery Patents, Signaling Pharmaceutical Innovation Boom

Drug Patent Watch

China is emerging as a global frontrunner in patenting artificial intelligence (AI) technologies for drug discovery, particularly in the field […] Source

95
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Rising Iceberg of Lyophilized Innovations

PharmaTech

The increased demand for biopharmaceutical products is increasing the demand for lyophilization innovations and services.

69
article thumbnail

Which pharmaceutical companies have the most insert dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most insert dosed drugs. For a different perspective, see the most popular dosage types.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

The Crucial Role of Pharmaceutical Impurity Reference Standards in Quality Control

Pharma Mirror

Ensuring the safety and efficacy of pharmaceutical products is paramount in the healthcare industry. Pharmaceutical impurity reference standards play a critical role in this process by helping to identify and quantify impurities. Understanding their importance can significantly enhance quality control measures in drug development and production. In today’s pharmaceutical industry, maintaining high-quality standards is not just a regulatory requirement but also an ethical obligation.

article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

59
article thumbnail

Data-Driven Development: How Real-World Data and AI Are Transforming Clinical Trials

Pharmacy Times

Real-world data and artificial intelligence (AI) are poised to revolutionize drug development by optimizing clinical trials and regulatory approvals, if data quality and patient privacy challenges are addressed.